BRAND NAME:
Lipofen

GENERIC NAME:
Fenofibrate

THERAPEUTIC SEGMENT:
Anti- Lipidemic

INDICATIONS:
• Hypertriglyceridemia
• Hypercholesterolemia

BRIEF DESCRIPTION:
Fenofibrate is a fibric acid derivative whose lipid modifying effects reported in humans are mediated via activation of Peroxisome Proliferator Activated Receptor type alpha (PPARa). Through activation of PPARa, fenofibrate increases the lipolysis and elimination of atherogenic triglyceride-rich particles from plasma by activating lipoprotein lipase and reducing production of apoprotein CIII. Activation of PPARa also induces an increase in the synthesis of apoproteins AI and All.

DOSAGE FORM:
Capsules 67mg and 200mg

PACK SIZE:
Capsules 67mg are available in blister pack of 30’s.
Capsules 200mg are available in blister pack of 10’s.